“Our real-life observational single-center study suggests that medical cannabis may provide benefits for some patients with dystonia,” researchers concluded.
Topic: Health/Safety
“[T]he odds of developing T2DM [type 2 diabetes] in individuals exposed to cannabis was 0.48 times lower than in those without cannabis exposure,” the study’s authors concluded.
“Liver transplant candidates who use cannabis should not be denied access to transplantation,” investigators concluded.
“These encouraging results suggest that further multicenter, larger, randomized, controlled trials of longer-term are warranted.”
“There were significant reductions in pain [at] all doses,” the study’s authors concluded
Authors concluded, “A history of monthly cannabis use for more than one year was not independently associated with either increased blood pressure or prevalent hypertension.”
Following legalization, “there is a clear, immediate, statistically significant decrease in total admissions. The effect becomes more pronounced as time goes on.”
The topical application of hemp-derived cannabinoids produced results that were superior to those associated with prescription treatments.